SMEInst-05-2016-2017
SMEInst-05-2016-2017
107 projects · €112,881,738 total EU contribution (project-level) · 108 participating organizations · 21 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€112,881,738
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (15)
- Spain (13)
- France (11)
- Italy (10)
- SE (10)
- IL (8)
- Germany (7)
- Netherlands (6)
- PT (6)
- DK (4)
- IE (3)
- PL (3)
- AT (2)
- IS (2)
- NO (2)
- BE (1)
- CZ (1)
- EE (1)
- HU (1)
- SI (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- AENITIS TECHNOLOGIES2 projects · FR
- EBERS2 projects · ES
- THE ZEBRAFISH LAB2 projects · ES
- METAFORA BIOSYSTEMS2 projects · FR
- SYMCEL2 projects · SE
- 2CUREX A/S1 projects · DK
- 2CUREX GMBH1 projects · DE
- AMADIX1 projects · ES
- AEQUOR1 projects · UK
- AGLARIS1 projects · UK
- ALLTOX1 projects · IT
- ALTRATECH LIMITED1 projects · IE
Projects
Page 9 of 11
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Industrial Production of Stable Fibroblast Growth Factors for Regenerative Medicine and Related Research Areas FGFSTAB · 756471 | H2020 | €1,030,000 | €1,030,000 | Details |
OvaRenew as a first-line therapy in impaired egg quality treatment OvaRenew · 743905 | H2020 | €50,000 | €71,429 | Details |
New high-performance excipients in pharmaceutical industry: an innovative solution for a more efficient and sustainable drug manufacturing process. HPE1 · 744285 | H2020 | €50,000 | €71,429 | Details |
Normothermic Perfusion Device for Renal and Hepatic Preservation and Viability Assessment NORMOPERF · 804252 | H2020 | €2,570,850 | €2,570,850 | Details |
X-10 Pathology, Empowering diagnostics X-10 Pathology · 734969 | H2020 | €50,000 | €71,429 | Details |
On-line Dialysis Sensor Phase2 OLDIAS2 · 767572 | H2020 | €2,823,952 | €2,823,952 | Details |
IBEX QDR: A Ground-breaking Technological Upgrade based on Quantitative Digital Radiography to Exploit the Full Diagnostic Potential of Standard Digital X-Ray IBEX QDR · 777835 | H2020 | €1,611,543 | €1,611,543 | Details |
Commercialization of TREG cells sorting and proliferation in vitro for the production of vaccines for the treatment of type 1 diabetes. TREGS4DM1 · 729891 | H2020 | €50,000 | €71,429 | Details |
Acoustic Blood Cells Sorter ABC-S · 783667 | H2020 | €3,951,479 | €3,951,480 | Details |
Revolutionary opto-biological methodology for aggressive HER2 cancer SDS-OmiProbe · 783818 | H2020 | €3,985,000 | €3,985,000 | Details |